Control group:Radiofrequency Ablation (RFA)

2 trials

Sponsors

Shandong Cancer Prevention and Treatment Institute, West China Hospital of Sichuan University

Conditions

Hepatocellular CarcinomaParoxysmal supraventricular tachycardia

Phase 4

A randomized, controlled, open-label clinical study of Radiofrequency Ablation (RFA) combined with Camrelizumab for Hepatocellular Carcinoma

RecruitingChiCTR2000039093

Shandong Cancer Prevention and Treatment InstituteHepatocellular Carcinoma

Start: 2020-10-20Updated: 2021-01-18

Unknown Phase

A Multicenter Randomized Comparative Study of Pulsed Electric Field and Radiofrequency Ablation in the Treatment of Paroxysmal Supraventricular Tachycardia

Active, not recruitingChiCTR2600123476

West China Hospital of Sichuan UniversityParoxysmal supraventricular tachycardia

Start: 2026-04-27Updated: 2026-05-04